Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
89
NCT00003403
GPX-100 in Treating Patients With Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 1999
Completion: Not specified
NCT00123877
Study of GPX-100 in the Treatment of Metastatic Breast Cancer
Phase: Phase 2
Start: Mar 31, 2005
Completion: Nov 30, 2005
NCT00710125
Safety Study of GPX-150 in Patients With Solid Tumors
Start: Jan 31, 2008
Completion: Oct 31, 2013
NCT02267083
Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma
Start: Jan 7, 2015
Completion: Aug 18, 2016